1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
- 2023
-
Mark
A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Proteogenomic mapping sets stage for precision medicine
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Postprandial glycaemic dips predict appetite and energy intake in healthy individuals
(
- Contribution to journal › Article
- 2020
-
Mark
Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta cells
(
- Contribution to journal › Letter
-
Mark
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
(
- Contribution to journal › Article
- 2019
-
Mark
Pancreatic β-cell mRNA modification as a marker for type 2 diabetes
(
- Contribution to journal › Scientific review